Hemobilia: review of recent experience with a worldwide problem.
Between 1981 and 1985, the reported incidence of hemobilia increased for two major reasons. First, a more sophisticated and better-trained medical community could entertain the diagnosis readily in certain settings and had broader access to diagnostic methods that precisely defined the source of bleeding into the biliary tract. Second, there was wider use of percutaneous techniques of diagnosis and treatment of biliary diseases. Once the diagnosis of hemobilia was made by endoscopic or arteriographic means, physicians and surgeons were quicker to institute proper therapeutic measures. For this reason, the mortality associated with hemobilia decreased compared with that reported earlier. The medical community must be aware that modern treatments are now the most common cause of this problem. Since invasive diagnostic methods are increasingly used by nonsurgeons, it is imperative that these patients are studied in the context of complete consultation with surgeons who can use definitive treatments when required.
D000007:Abdominal Injuries / Q000150:complications; D000293:Adolescent; D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects; D001706:Biopsy / Q000009:adverse effects; D002648:Child; D004322:Drainage / Q000009:adverse effects; D005260:Female; D006431:Hemobilia / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D006801:Humans; D007049:Iatrogenic Disease; D008099:Liver / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010192:Pancreatic Pseudocyst / Q000150:complications
D000925:Anticoagulants